Company Filing History:
Years Active: 2011
Title: Jochen Neu: Innovator in Azaindazole Compounds
Introduction
Jochen Neu is a notable inventor based in Mittelbiberach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors involved in autoimmune diseases. With a total of 2 patents, his work is paving the way for new therapeutic options.
Latest Patents
Jochen Neu's latest patents focus on Azaindazole compounds as CCR1 receptor antagonists. These compounds are disclosed as useful for treating a variety of diseases and disorders mediated or sustained through the activity of CCR1. This includes autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The patents also detail methods of making and using these compounds, showcasing their potential in medical applications.
Career Highlights
Jochen Neu is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves extensive research and development in the field of drug discovery, where he applies his expertise to create innovative solutions for complex health issues.
Collaborations
Throughout his career, Jochen has collaborated with several talented individuals, including Brian Nicholas Cook and Christian Harcken. These collaborations have enhanced his research efforts and contributed to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Jochen Neu's work in the development of Azaindazole compounds represents a significant advancement in the treatment of autoimmune diseases. His contributions to the field, along with his collaborations, highlight the importance of innovation in medical research.